Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02954835 · ClinicalTrials.gov registry record · Phase 4
Negative Pressure Therapy for Groin Wounds
A Phase 4 study, sponsored by Englewood Hospital and Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02954835: Completed Phase 4 study, sponsored by Englewood Hospital and Medical Center.
NCT02954835 is a Phase 4 study that has completed, run by Englewood Hospital and Medical Center. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02954835, a Phase 4 study, has completed, sponsored by Englewood Hospital and Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare wound infection rates between negative pressure therapy (Prevena) and the traditional sterile dry dressing among patients undergoing vascular surgery involving groin incisions.
Interventions
- DEVICE Prevena
- DEVICE Traditional Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-09-03 |
| Phase | Phase 4 |
What the finished NCT02954835 record still lists
NCT02954835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Prevena is the first listed.
NCT02954835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02954835 about?
NCT02954835 is a clinical study titled "Negative Pressure Therapy for Groin Wounds". The purpose of this study is to compare wound infection rates between negative pressure therapy (Prevena) and the traditional sterile dry dressing among patients undergoing vascular surgery involving groin incisions.
What is the current status of trial NCT02954835?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2016-12. Estimated completion is 2019-09-03.
What interventions are being tested in trial NCT02954835?
The interventions under investigation include: Prevena (DEVICE), Traditional Dressing (DEVICE).
Who is sponsoring clinical trial NCT02954835?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02954835's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia